Literature DB >> 15853502

Uses of topiramate in the treatment of alcohol dependence.

Bankole A Johnson1.   

Abstract

Alcohol dependence is a major cause of morbidity and mortality in the USA and throughout the world. Over the last 10 years there has been an intense interest in developing pharmacotherapies that address the neurochemistry of alcohol dependence. Using a novel pharmacological approach to treating alcohol dependence, topiramate (Topamax, Ortho-McNeil Pharmaceutical) has recently been shown to improve the drinking outcomes of alcohol-dependent individuals. This drug profile highlights the scientific concepts and clinical evidence in the development of topiramate for treating alcohol dependence.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15853502     DOI: 10.1586/14737175.4.5.751

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  8 in total

1.  Metabolism and excretion of the antiepileptic/antimigraine drug, Topiramate in animals and humans.

Authors:  G W Caldwell; W N Wu; J A Masucci; L A McKown; D Gauthier; W J Jones; G C Leo; B E Maryanoff
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2005 Jul-Sep       Impact factor: 2.441

Review 2.  Topiramate in Alcohol Use Disorders: Review and Update.

Authors:  Riccardo Guglielmo; Giovanni Martinotti; Marianna Quatrale; Lucia Ioime; Irket Kadilli; Marco Di Nicola; Luigi Janiri
Journal:  CNS Drugs       Date:  2015-05       Impact factor: 5.749

Review 3.  Molecular targets of alcohol action: Translational research for pharmacotherapy development and screening.

Authors:  Giorgio Gorini; Richard L Bell; R Dayne Mayfield
Journal:  Prog Mol Biol Transl Sci       Date:  2011       Impact factor: 3.622

4.  Severity of drinking as a predictor of efficacy of the combination of ondansetron and topiramate in rat models of ethanol consumption and relapse.

Authors:  Wendy J Lynch; Colin Bond; Florence J Breslin; Bankole A Johnson
Journal:  Psychopharmacology (Berl)       Date:  2011-03-22       Impact factor: 4.530

Review 5.  [Pharmacological relapse prevention in alcohol and tobacco dependence].

Authors:  A Diehl; K Mann
Journal:  Internist (Berl)       Date:  2007-01       Impact factor: 0.743

6.  Effects of topiramate on ethanol-cocaine interactions and DNA methyltransferase gene expression in the rat prefrontal cortex.

Authors:  V Echeverry-Alzate; E Giné; K M Bühler; J Calleja-Conde; P Olmos; M A Gorriti; R Nadal; F Rodríguez de Fonseca; J A López-Moreno
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

Review 7.  Molecular pharmacodynamics, clinical therapeutics, and pharmacokinetics of topiramate.

Authors:  Richard P Shank; Bruce E Maryanoff
Journal:  CNS Neurosci Ther       Date:  2008       Impact factor: 5.243

8.  Topiramate does not alter nicotine or cocaine discrimination in rats.

Authors:  Bernard Le Foll; Zuzana Justinova; Carrie E Wertheim; Chanel Barnes; Steven R Goldberg
Journal:  Behav Pharmacol       Date:  2008-02       Impact factor: 2.293

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.